After the Covid 19 Pandemic, trade fairs restart including the AFI Symposium. Also for this year, PlumeStars participated at the 61st AFI Symposium, the Italian Conference of the Industrial Pharmacists, held on 8th, 9 th and 10 th June at the new Pala Congressi in Rimini.
On 22nd and 29th April 2021, PlumeStars organizes the Two day web course “Quality by Design in Pharmaceutical and Food Development. Theory and case studies”.
Read more “Web seminar “Quality by Design in Pharmaceutical and Food Development. Theory and case studies””
9-10 DECEMBER: TWO DAY SEMINAR “QUALITY BY DESIGN IN PHARMACEUTICAL DEVELOPMENT: THEORY AND CASE STUDIES”, IN COLLABORATION WITH UNIVERSITY OF PARMA
On 9th and 10 th December 2019, at the Department of Food and Drug of the University of Parma, the two days course “Quality by Design in Pharmaceutical Development. Theory and case studies”, will take place.
Read more “9-10 DECEMBER: TWO DAY SEMINAR “QUALITY BY DESIGN IN PHARMACEUTICAL DEVELOPMENT: THEORY AND CASE STUDIES”, IN COLLABORATION WITH UNIVERSITY OF PARMA”
From 3rd to 6th of November, PlumStars will participate at AAPS 2019 AAPS, an annual Conference of the American Association of Pharmaceutical Scientists that will be held at Henry B. González Convention Center, San Antonio, TX, USA.
There will be pitching, demonstrations and great presentations, with take-aways for both investors and innovation driven organizations.
Prof. Paolo Colombo (PlumeStars CEO) will present two different speeches:
- “Hyaluronic-Cisplatin Film for Implant for Malignant Mesothelioma Recurrences”.
- “Flurbiprofen powders for nose-to-brain delivery as alzheimer’s disease modifying agent”.
The first speech concerns Hyalcis exploits nanotechnology and advanced material research results to bring to market an innovative medical treatment of mesothelioma. The studies until now conducted revealed an interaction between the polymer hyaluronic acid and cisplatin that gave rise to a drug-polymer complex, lymphatically absorbed and blood distributed.
The uptake by pharmaceutical industry of the hyaluronic- cisplatin film technology studied by PlumeStars will assign a more effective cure against recurrences of this rare and very aggressive form of cancer that is difficult to diagnose and highly resistant to anticancer drugs.
Dr. Eride Quarta (PharmD; PhD Student, PlumeStars Research Leader) will present:
- “Novel Insulin Powder: bioavalability in rats”.
AAPS PharmSci 360 combines all the energy of a large scientific conference with the intimacy of a niche meeting.
Five robust tracks covering all aspects of the pharmaceutical sciences, hundreds of exhibitors with dozens of additional learning opportunities, thousands of scientific posters featuring the latest, most innovative research in the field.
16 May: Pre-conference workshop “Medicines for rare diseases” , in collaboration with University of Parma
When: 16 May 2018
Where: Aula Magna, Via Università 12, Parma (Italy)
Subject: Pre-conference workshop “Medicines for rare diseases”
Read more “16 May: Pre-conference workshop “Medicines for rare diseases” , in collaboration with University of Parma”
When: 12-13 April 2018
Where: Pharmacy Building (Room C), Campus Univeristy of Parma, Viale Parco Area delle Scienze 27/A (Pr)
Subject:Quality by Design in Pharmaceutical Development: theory and case studies
Read more “12-13 April: Two Day seminar QbD, in collaboration with University of Parma”